Rapid improvement of hepatic steatosis after initiation of leptin substitution in a leptin-deficient girl

Hormone Research in Paediatrics

Volumn 79, Issue 5, 2013, Pages 310-317

  Von Schnurbein, J ^a   Heni, M ^b   Moss, A ^a   Nagel, S A ^a   MacHann, J ^b   Muehleder, H ^c   Debatin, K M ^a   Farooqi, S ^d   Wabitsch, M ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Children's Hospital Wels   (Austria)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Hormone replacement therapy; Insulin resistance; Leptin; Non alcoholic fatty liver disease; Obesity

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; RECOMBINANT LEPTIN; AMINOTRANSFERASE; LEPTIN; METRELEPTIN;

ADOLESCENT; ARTICLE; BODY FAT; CALORIC INTAKE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; FATTY LIVER; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LEPTIN DEFICIENCY; LIPID LIVER LEVEL; LIPODYSTROPHY; PRIORITY JOURNAL; AMINOTRANSFERASE BLOOD LEVEL; FAT CONTENT; GENE MUTATION; NUCLEAR MAGNETIC RESONANCE;

ADOLESCENT; CHOLESTEROL; FATTY LIVER; FEMALE; HOMOZYGOTE; HORMONE REPLACEMENT THERAPY; HUMANS; LEPTIN; LIPOPROTEINS, LDL; LIVER; MUTATION; TIME FACTORS;

EID: 84879421084     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000348541     Document Type: Article

References (45)

1. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S: Beneficial effects of leptin on obesity, T-cell hyporesponsiveness, and neuroen-docrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002; 110:1093-1103.
2. Javor ED, Ghany MG, Cochran EK, Oral EA, DePaoli AM, Premkumar A, Kleiner DE, Gorden P: Leptin reverses nonalcoholic ste-atohepatitis in patients with severe lipodys-trophy. Hepatology 2005; 41:753-760.
3. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269:540-543.
4. Shimomura I, Bashmakov Y, Horton JD: Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 1999; 274:30028-30032.
5. Kakuma T, Lee Y, Higa M, Wang Z, Pan W, Shimomura I, Unger RH: Leptin, troglit-azone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci USA 2000; 97: 8536-8541.
6. Brix AE, Elgavish A, Nagy TR, Gower BA, Rhead WJ, Wood PA: Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse. Mol Genet Metab 2002; 75:219-226.
7. Lu H, Sun J, Sun L, Shu X, Xu Y, Xie D: Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in china. J Gastroenterol Hepatol 2009; 24: 228-232.
8. Nobili V, Manco M, Ciampalini P, Diciommo V, Devito R, Piemonte F, Comparcola D, Gui-di R, Marcellini M: Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol 2006; 155:735-743.
9. Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, Liddle C, Samarasinghe D, George J: Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 2002; 36:403-409.
10. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Haring HU: Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609-1616.
11. Huang-Doran I, Sleigh A, Rochford JJ, O'Rahilly S, Savage DB: Lipodystrophy: metabolic insights from a rare disorder. J Endocri-nol 2010; 207:245-255.
12. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Krober SM, Machicao F, Fritsche A, Haring HU: Alpha-2-Heremans-Schmid gly-coprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006; 29:853-857.
13. Paz-Filho GJ, Ayala A, Esposito K, Erol HK, Delibasi T, Hurwitz BE, Wong ML, Licinio J: Effects of leptin on lipid metabolism. Horm Metab Res 2008; 40:572-574.
14. Muzzin P, Eisensmith RC, Copeland KC, Woo SL: Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci USA 1996; 93:14804-14808.
15. Licinio J, Caglayan S, Ozata M, Yildiz BO, de Miranda PB, O'Kirwan F, Whitby R, Liang L, Cohen P, Bhasin S, Krauss RM, Veldhuis JD, Wagner AJ, DePaoli AM, McCann SM, Wong ML: Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogo-nadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci USA 2004; 101: 4531-4536.
16. Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P: Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 2005; 54:1994-2002.
17. Oral EA, Javor ED, Ding L, Uzel G, Cochran EK, Young JR, DePaoli AM, Holland SM, Gorden P: Leptin replacement therapy modulates circulating lymphocyte subsets and cyto-kine responsiveness in severe lipodystrophy. J Clin Endocrinol Metab 2006; 91:621-628.
18. Beltrand J, Beregszaszi M, Chevenne D, Sebag G, De Kerdanet M, Huet F, Polak M, Tubiana-Rufi N, Lacombe D, De Paoli AM, Levy-Marchal C: Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoat-rophy. Pediatrics 2007; 120:e291-e296.
19. Ebihara K, Kusakabe T, Hirata M, Masuzaki H, Miyanaga F, Kobayashi N, Tanaka T, Chusho H, Miyazawa T, Hayashi T, Hosoda K, Ogawa Y, DePaoli AM, Fukushima M, Na-kao K: Efficacy and safety of leptin-replace-ment therapy and possible mechanisms of leptin actions in patients with generalized li-podystrophy. J Clin Endocrinol Metab 2007; 92:532-541.
20. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI: Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002; 109:1345-1350.
21. Ozata M, Ozdemir IC, Licinio J: Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999; 84:3686-3695.
22. Gibson WT, Farooqi IS, Moreau M, DePaoli AM, Lawrence E, O'Rahilly S, Trussell RA: Congenital leptin deficiency due to homozy-gosity for the δ133g mutation: report of another case and evaluation of response to four years of leptin therapy. J Clin Endocrinol Metab 2004; 89:4821-4826.
23. Paz-Filho GJ, Babikian T, Asarnow R, Esposi-to K, Erol HK, Wong ML, Licinio J: Leptin replacement improves cognitive development. PLoS One 2008; 3:e3098.
24. Mazen I, El-Gammal M, Abdel-Hamid M, Amr K: A novel homozygous missense mutation of the leptin gene (N103k) in an obese Egyptian patient. Mol Genet Metab 2009; 97: 305-308.
25. Fatima W, Shahid A, Imran M, Manzoor J, Hasnain S, Rana S, Mahmood S: Leptin deficiency and leptin gene mutations in obese children from Pakistan. Int J Pediatr Obes 2011; 6:419-427.
26. Saeed S, Butt TA, Anwer M, Arslan M, Froguel P: High prevalence of leptin and melanocor-tin-4 receptor gene mutations in children with severe obesity from Pakistani consanguineous families. Mol Genet Metab 2012; 106:121-126.
27. Fischer-Posovszky P, von Schnurbein J, Moepps B, Lahr G, Strauss G, Barth TF, Kassu bek J, Muhleder H, Moller P, Debatin KM, Gierschik P, Wabitsch M: A new mis-sense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T-cell responsiveness. J Clin Endocrinol Metab 2010; 95:2836-2840.
28. Von Schnurbein J, Moss A, Nagel SA, Muehleder H, Debatin KM, Farooqi IS, Wabitsch M: Leptin substitution results in the induction of menstrual cycles in an adolescent with leptin deficiency and hypogonado-tropic hypogonadism. Horm Res Paediatr 2012; 77:127-133.
29. Matthews DR, Hosker JP, Rudenski AS, Nay-lor BA, Treacher DF, Turner RC: Homeosta-sis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabeto-logia 1985; 28:412-419.
30. Machann J, Thamer C, Schnoedt B, Haap M, Haring HU, Claussen CD, Stumvoll M, Frit-sche A, Schick F: Standardized assessment of whole-body adipose tissue topography by MRI. J Magn Reson Imaging 2005; 21:455-462.
31. 1H-MR spec-troscopy of skeletal muscle, liver and bone marrow. Eur J Radiol 2008; 67:275-284.
32. 1H-MR spectroscopy. Magn Reson Med 2006; 55:913-917.
33. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL: Magnetic resonance spec-troscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288:E462-E468.
34. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387:903-908.
35. Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese G, Keogh JM, Lank E, Bottomley B, Lopez-Fernandez J, Ferraz-Amaro I, Dat-tani MT, Ercan O, Myhre AG, Retterstol L, Stanhope R, Edge JA, McKenzie S, Lessan N, Ghodsi M, De Rosa V, Perna F, Fontana S, Barroso I, Undlien DE, O'Rahilly S: Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 2007; 356:237-247.
36. Clement K, Vaisse C, Lahlou N, Cabrol S, Pel-loux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bou-gneres P, Lebouc Y, Froguel P, Guy-Grand B: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392:398-401.
37. Anstee QM, Goldin RD: Mouse models in non-alcoholic fatty liver disease and steato-hepatitis research. Int J Exp Pathol 2006; 87: 1-16.
38. Strobel A, Issad T, Camoin L, Ozata M, Stros-berg AD: A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998; 18:213-215.
39. Simha V, Szczepaniak LS, Wagner AJ, De-Paoli AM, Garg A: Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized li-podystrophy. Diabetes Care 2003; 26:30-35.
40. Lee Y, Yu X, Gonzales F, Mangelsdorf DJ, Wang MY, Richardson C, Witters LA, Unger RH: PPAR-α is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc Natl Acad Sci USA 2002; 99: 11848-11853.
41. Asilmaz E, Cohen P, Miyazaki M, Dobrzyn P, Ueki K, Fayzikhodjaeva G, Soukas AA, Kahn CR, Ntambi JM, Socci ND, Friedman JM: Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest 2004; 113:414-424.
42. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB: Leptin stimulates fatty-acid oxidation by activating amp-activated protein kinase. Nature 2002; 415: 339-343.
43. Orci L, Cook WS, Ravazzola M, Wang MY, Park BH, Montesano R, Unger RH: Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad Sci USA 2004; 101:2058-2063.
44. Soukas A, Cohen P, Socci ND, Friedman JM: Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev 2000; 14:963-980.
45. Farooqi IS, O'Rahilly S: Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009; 89:980S-984S.